Macrophage Pharma has acquired 1 company.
The Company’s most targeted sectors include life science (100%).
4 Claridge Court Lower Kings Road,
Berkhamsted,
HP4 2AF
United Kingdom,
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2017-01-09 |
Chroma Therapeutics Ltd. - Esterase Sensitive Motif · Life Science
Abingdon, United Kingdom Chroma Therapeutics Ltd. - Esterase Sensitive Motif is a platform delivers small molecule drugs to tumour associated macrophages in a highly selective manner, thus activating the body's natural immune system to fight cancer. The platform has the ability to provide next-generation immunotherapies for a number of different cancers. |
- | Divestiture |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
